L C Kilgore
Overview
Explore the profile of L C Kilgore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnes M, Robertson 3rd M, Naumann R, Roland P, Alvarez R, Kilgore L, et al.
J Low Genit Tract Dis
. 2015 May;
2(2):93-7.
PMID: 25951467
Objective: Our aim was to determine whether histopathological variables predict persistent high-grade squamous intraepithelial lesions (HGSIL) after large-loop excision of the transformation zone (LLETZ). Materials And Methods: All patients with...
2.
Barnes M, Maxwell J, Roland P, Kilgore L
J Low Genit Tract Dis
. 2015 May;
1(4):260-2.
PMID: 25951213
Objectives: A case of small-cell carcinoma of the cervix and severe hypokalemia is presented. The need for surveillance of paraneoplastic syndromes in these patients is emphasized. Methods: The patient's clinical...
3.
Numnum T, Kimball K, Rocconi R, Kilgore L, Straughn Jr J
Int J Gynecol Cancer
. 2007 Mar;
17(5):1019-24.
PMID: 17386043
The objective is to assess the cost-effectiveness of pegfilgrastim for the prevention of hospitalization due to febrile neutropenia (FN) in patients with epithelial ovarian carcinoma (EOC) receiving taxane/platinum-based chemotherapy. A...
4.
Leath 3rd C, Numnum T, Straughn Jr J, Rocconi R, Huh W, Kilgore L, et al.
Int J Gynecol Cancer
. 2007 Mar;
17(5):998-1002.
PMID: 17367322
The aim is to evaluate disease-free (DFS) and overall survival (OS) of patients with fallopian tube carcinoma (FTCA) treated with adjuvant chemotherapy. An Institutional Review Board approved retrospective review identified...
5.
Huh W, Straughn Jr J, Kelly F, Kilgore L
Curr Treat Options Oncol
. 2002 Jun;
2(2):129-35.
PMID: 12057131
Endometrial cancer is a common tumor of the female genital tract. The majority of women diagnosed with endometrial cancer present with early-stage disease. Although the optimal treatment for these patients...
6.
Meredith R, Alvarez R, Partridge E, Khazaeli M, Lin C, Macey D, et al.
Cancer Biother Radiopharm
. 2001 Oct;
16(4):305-15.
PMID: 11603001
A phase I trial was designed to examine the feasibility of combining interferon and Taxol with intraperitoneal radioimmunotherapy (177Lu-CC49). Patients with recurrent or persistent ovarian cancer confined to the abdominal...
7.
Miller D, Blessing J, Kilgore L, Mannel R, Van Le L
Am J Clin Oncol
. 2000 Aug;
23(4):355-7.
PMID: 10955863
From October 1995 to March 1997, a phase II trial of topotecan was carried out in chemotherapy-naive women with advanced, persistent, or recurrent uterine leiomyosarcomas. Thirty-six patients were entered. Median...
8.
Barnes M, Kilgore L
Semin Radiat Oncol
. 2000 Feb;
10(1):3-7.
PMID: 10671652
Endometrial adenocarcinoma is the most common gynecologic malignancy. Strategies for treatment of this disease should not only emphasize quality of care resulting in cure of disease, but also use health...
9.
Barnes M, Roland P, Straughn M, Kilgore L, Alvarez R, Partridge E
Gynecol Oncol
. 1999 Sep;
74(3):443-7.
PMID: 10479507
Objective: The aim of this study was to investigate the influence of three treatment strategies for adenocarcinoma of the endometrium on the utilization of adjuvant radiation therapy and the medical...
10.
Naumann R, Alvarez R, Omura G, Segars E, Kilgore L, Partridge E
Gynecol Oncol
. 1999 Jan;
71(3):450-3.
PMID: 9887248
Objective: Although doxorubicin is not currently popular as a primary agent in ovarian cancer, overviews of previous studies suggest that the inclusion of doxorubicin may have improved outcome. The purpose...